However, unlike the in vivo studies involving mouse models of AD treated with CuII(gstm), these experiments were performed on non-transfected cells that did not overexpress the amyloid precursor protein (APP) and therefore Aβ. The gene discussed is APP; the disease is Alzheimer disease.